Tuesday, October 19, 2021
1:00pm Eastern Time
Meredith Regan, ScD
Associate Professor
Department of Data Science, Dana-Farber Cancer Institute,
Harvard Medical School
Treatment-free Survival as a Novel Outcome Measure of Immuno-oncology-based Therapy
